Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,709Revenue (TTM) $M915Net Margin (%)-1.3Altman Z-Score0.9
Enterprise Value $M3,307EPS (TTM) $-0.1Operating Margin %2.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-8.7Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %--Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow7.7y-y EBITDA Growth Rate %35.3ROA % (ttm)-0.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-0.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M161ROIC % (ttm)-3.8Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJulian Robertson 2016-09-30 Reduce-1.17%$16.72 - $23.19
($19.54)
$ 16.80-14%Reduce -24.66%673,933
HZNPKen Heebner 2016-09-30 Buy 0.86%$16.72 - $23.19
($19.54)
$ 16.80-14%New holding1,000,000
HZNPSteve Mandel 2016-06-30 Sold Out -1.15%$13.41 - $18.82
($16.18)
$ 16.804%Sold Out0
HZNPKen Heebner 2016-06-30 Sold Out -0.23%$13.41 - $18.82
($16.18)
$ 16.804%Sold Out0
HZNPJoel Greenblatt 2016-06-30 Sold Out -0.2%$13.41 - $18.82
($16.18)
$ 16.804%Sold Out0
HZNPJulian Robertson 2016-06-30 Add0.14%$13.41 - $18.82
($16.18)
$ 16.804%Add 3.01%894,577
HZNPJoel Greenblatt 2016-03-31 Reduce-0.24%$14.02 - $21.67
($17.57)
$ 16.80-4%Reduce -49.21%1,053,933
HZNPJulian Robertson 2016-03-31 Add0.19%$14.02 - $21.67
($17.57)
$ 16.80-4%Add 5.45%868,477
HZNPSteve Mandel 2016-03-31 Reduce-0.15%$14.02 - $21.67
($17.57)
$ 16.80-4%Reduce -10.28%13,997,232
HZNPKen Heebner 2016-03-31 Add0.09%$14.02 - $21.67
($17.57)
$ 16.80-4%Add 60.98%330,000
HZNPJulian Robertson 2015-12-31 Buy 2.3%$13.12 - $22.58
($19.53)
$ 16.80-14%New holding823,577
HZNPJoel Greenblatt 2015-12-31 Buy 0.49%$13.12 - $22.58
($19.53)
$ 16.80-14%New holding2,075,017
HZNPKen Heebner 2015-12-31 Buy 0.15%$13.12 - $22.58
($19.53)
$ 16.80-14%New holding205,000
HZNPRon Baron 2015-12-31 Sold Out $13.12 - $22.58
($19.53)
$ 16.80-14%Sold Out0
HZNPSteve Mandel 2015-09-30 Add1.03%$16.81 - $38.45
($31.59)
$ 16.80-47%Add 386.77%15,600,988
HZNPRon Baron 2015-09-30 Buy $16.81 - $38.45
($31.59)
$ 16.80-47%New holding31,999
HZNPSteve Mandel 2015-06-30 Buy 0.42%$25.6 - $34.74
($30.45)
$ 16.80-45%New holding3,204,972
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 16.80-8%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 16.8034%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 16.8046%Add 39.93%80,834
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-08-02Sell2,900$20-16view
Nohria VirinderDirector 2016-06-15Sell25,000$17.69-5.03view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-02-26Sell4,100$20-16view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-12-10Sell4,456$20-16view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-09-21Sell7,750$31.78-47.14view
Watkins ThomasDirector 2015-08-19Buy10,000$31.32-46.36view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-52.74view
Himawan JeffDirector 2015-03-13Sell554,564$22.44-25.13view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.85-23.11view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.0539.42view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Julian Robertson Sells Delta Air Lines, Alphabet Dec 07 2016 
Julian Robertson Buys 8 New Stakes in 4th Quarter Mar 09 2016 
Sheets Smith Wealth Management Buys Companies With no Debts Sep 01 2015 
Horizon Pharma Leads Stock Returns in Health Care Industry Aug 24 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 

More From Other Websites
[$$] Drugmakers alarmed by Trump pricing threat Jan 14 2017
Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : January 11,... Jan 11 2017
HORIZON PHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition Jan 10 2017
ETFs with exposure to Horizon Pharma Plc : January 9, 2017 Jan 09 2017
Horizon's Rare Disease Drug Quinsair Launched in Canada Dec 27 2016
Valeant Pharmaceuticals: A Trump Winner or Loser? Dec 23 2016
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Dec 22 2016
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Dec 22 2016
HORIZON PHARMA PLC Files SEC form 8-K/A, Financial Statements and Exhibits Dec 22 2016
Horizon Pharma plc Announces Availability of QUINSAIR™ (levofloxacin inhalation solution) in... Dec 22 2016
Horizon Pharma plc to Present at the 35th Annual J.P. Morgan Healthcare Conference Dec 22 2016
Horizon Pharma plc Announces Availability of QUINSAIR™ (levofloxacin inhalation solution) in... Dec 22 2016
What Are Analysts Saying about Horizon Pharma? Dec 21 2016
Understanding Horizon Pharma’s Revenue Growth beyond 2016 Dec 21 2016
Revenue Drivers for Krystexxa, Horizon’s Orphan Biologic Drug Dec 21 2016
Gauging the Performance of Horizon Pharma’s Rayos in 3Q16 Dec 20 2016
Horizon Pharma’s Orphan Drug Segment: 3Q16 Performance Dec 20 2016
It Was a Successful 3Q16 for Horizon Pharma’s Primary Care Dec 20 2016
How Did Horizon Pharma Perform in 3Q16? Dec 19 2016
Factors behind Horizon Pharma’s Volatility in December Dec 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)